United States · Platforms & data · MarketBeat
Zymeworks (NASDAQ:ZYME) to Buy Back $200 million in Stock

Detailed summary
Zymeworks (NASDAQ:ZYME - Get Free Report) declared that its Board of Directors has approved a stock buyback plan on Monday, November 16th, RTT News reports. The company plans to buy back $200 million in outstanding shares. This repurchase authorization allows the company to buy up to 10.9% of its stock through open market purchases.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)



